Health Catalyst Inc reports results for the quarter ended in September 30 - Earnings Summary

• Health Catalyst Inc HCAT.OQ reported quarterly adjusted earnings of 7 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 3 cents. The mean expectation of fourteen analysts for the quarter was for earnings of 10 cents per share. Wall Street expected results to range from 5 cents to 16 cents per share.

• Revenue rose 3.5% to $76.35 million from a year ago; analysts expected $76.30 million.

• Health Catalyst Inc's reported EPS for the quarter was a loss of 24 cents​.

• The company reported a quarterly loss of $14.73 million.

• Health Catalyst Inc shares had fallen by 4.7% this quarter and lost 16.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 2.7% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the software peer group is also "buy"

Wall Street's median 12-month price target for Health Catalyst Inc is 11.00

This summary was machine generated from LSEG data November 7 at 04:48 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)